News
CATALIS is now implementing its new strategic plan with the creation of new advisory committees
CATALIS is now implementing its new strategic plan with the creation of new advisory committees Since 2018, CATALIS’s operational activities have been guided essentially by an advisory committee composed of research centre administrators, pharmaceutical industry members, and government representatives. In 2021, given that the new strategic plan extends the scope of CATALIS’s actions, two new advisory committees will be created: a
CATALIS has great plans for the coming year.
CATALIS has great plans for the coming year. A message from the chairman of the CATALIS board of directors, Dr. Marc Rivière There is no doubt that this past year has been disconcerting and most unusual. Clinical research was confronted with substantial challenges that highlighted our system’s ability to adapt quickly and find innovative solutions. This exceptional situation caused us to
Boehringer Ingelheim and Sanofi Join the CATALIS Network
Boehringer Ingelheim and Sanofi Join the CATALIS Network New pharmaceutical industry partners are supporting CATALIS in making Quebec a world leader in clinical research. MONTREAL, May 20, 2021 —CATALIS Québec is proud to announce that two pharmaceutical companies, Boehringer Ingelheim and Sanofi, have joined its network of partners who are working together to support Quebec’s competitiveness in conducting clinical trials.
Diffusion of the updated “Standard legal clauses for information and consent forms for clinical trials”
Diffusion of the updated “Standard legal clauses for information and consent forms for clinical trials” CATALIS Québec is pleased to announce that the revised version of the “Standard legal clauses for information and consent forms for clinical trials” has been published by the ministry of health and social services (MSSS). The original legal clauses for consent forms, published in 2016
CATALIS Quebec announces the rolls out the 2nd phase of Nagano clinical trial evaluation management system synchronization in the Quebec’s health and social services institutions
CATALIS Quebec announces the rolls out the 2nd phase of Nagano clinical trial evaluation management system synchronization in the Quebec’s health and social services institutions Since 2010, majority of public institutions in Quebec’s health and social services network have gradually integrated the Nagano computer system, a platform that makes the administrative management of research projects, including clinical trials’ evaluation and
World-Class Clinical Research Professionals
World-Class Clinical Research Professionals Since October 2019, Arnaud Villier has been the coordinator of start-up operations at the Unit for Innovative Therapies at Montréal’s CHUM Research Centre. “It is a job where you have to make sure that each of the steps that precede the start of a clinical trial in patients is completed in accordance with good clinical practice
CATALIS Québec and AQIIRC are launching a joint advanced training bursary program
CATALIS Québec and AQIIRC are launching a joint advanced training bursary program CATALIS Québec and the Association québécoise des infirmières et intervenants en recherche clinique (AQIIRC) are launching a joint advanced training bursary program to support the development of Quebec’s clinical research professionals. Bursaries in the amount of CAN$350 each are being offered to clinical research professionals registering for the
Message from the President
Message from the President I am delighted to be joining CATALIS Québec in order to contribute to the development of clinical research in Quebec and to foster solidarity between all industry stakeholders to improve the care of patients suffering from currently incurable diseases. As the new President, I would like to take this opportunity to report on the exceptional and
Appointment of Dr. Michael Sebag to CATALIS Québec’s Board
Appointment of Dr. Michael Sebag to CATALIS Québec’s Board CATALIS Québec is pleased to announce that Dr. Michael Sebag will be joining its Board of Directors as of June 18, 2020. A researcher at the McGill University Health Centre (MUHC) since 2009, Dr. Sebag has participated in an impressive number of clinical studies which provided access to innovative treatments to
Appointment of Jacques Hendlisz as CATALIS Québec’s New Executive President
Appointment of Jacques Hendlisz as CATALIS Québec’s New Executive President CATALIS Quebec is proud to welcome Mr. Jacques Hendlisz to the organization as its new Executive President, effective April 1, 2020. Mr. Hendlisz is widely recognized for his extensive experience in the management of both research and hospital facilities. He served as the Douglas Institute’s Director General from 1994 to